Coronavirus Disease 2019 (COVID-19)
FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.
Topic Paragraphs
Featured Topics
FDA Monkeypox Response
The FDA’s multipronged response to monkeypox includes efforts in the areas of diagnostics, vaccines and therapeutics.
Infant Formula Information and Resources
The FDA continues to work around the clock with our government partners and industry to ensure there's adequate infant formula available wherever and whenever parents and caregivers need it.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Oct 04
Swiss American Participates in Manufacturer Old Europe’s Recall of Brie and Camembert
Food & Beverages
Sep 30
Whole Foods Market Issues Allergy Alert for Zerto Fontal Cheese Sold in Connecticut, New Jersey, and New York
Food & Beverages
Sep 30
Old Europe Cheese, Inc. Issues Voluntary Recall of Its Brie and Camembert Cheeses Due to Possible Health Risk
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA Continues Important Work on Substance Use and Overdose Prevention Efforts
We remain committed to taking new steps to confront the overdose crisis.
FDA Issues New Guidance to Help Facilitate Availability of Naloxone to Prevent Opioid Overdoses and Reduce Death
The FDA is building on our actions by helping facilitate the availability and access to this life saving medication.
Using A Whole-Of-Governments Approach to Combating Illicit Health Products
A whole-of-governments approach is the best way to protect the public health from the trade of illicit health products.
Recently Published Guidances
Oct 03
Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules
Drugs
Oct 03
Facility Readiness: Goal Date Decisions Under GDUFA
Drugs
Oct 03
FDA and Industry Actions on Premarket Notification (510(k)) Submissions: Effect on FDA Review Clock and Goals
Biologics, Medical Devices